ZPRÁVA O PRŮBĚHU KLINICKÉHO HODNOCENÍ REMED (12. 2. 2021 – 11. 2. 2022)

Warning

This publication doesn't include Faculty of Sports Studies. It includes Faculty of Medicine. Official publication website can be found on muni.cz.
Title in English REPORT ON THE PROGRESS OF THE REMED CLINICAL EVALUATION (February 12, 2021 – February 11, 2022)
Authors

DEMLOVÁ Regina GRODOVÁ Karolína MALÁSKA Jan

Year of publication 2022
MU Faculty or unit

Faculty of Medicine

Web REMED
Description REMED is national, multicentre clinical trial carried out by the University Hospital Brno in cooperation with RI CZECRIN. The primary objective of the study is to test the hypothesis that administration of dexamethasone 20 mg daily is more effective with COVID-19 compared to a daily dose of dexamethasone 6 mg in adult patients with moderate or severe ARDS. During year 2021 was eight newsletters prepared and sent to clinical sites.
Related projects:

You are running an old browser version. We recommend updating your browser to its latest version.

More info